[DPHARMA] QoQ Quarter Result on 31-Mar-2021 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
03-May-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Mar-2021 [#1]
Profit Trend
QoQ- 8.78%
YoY- 29.89%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 145,444 171,838 155,439 166,454 134,086 133,772 143,331 0.97%
PBT 17,128 22,483 20,197 23,176 20,471 18,568 19,391 -7.91%
Tax -1,412 -5,520 -4,807 -5,562 -4,278 -4,441 -4,662 -54.80%
NP 15,716 16,963 15,390 17,614 16,193 14,127 14,729 4.40%
-
NP to SH 15,716 16,963 15,390 17,614 16,193 14,127 14,729 4.40%
-
Tax Rate 8.24% 24.55% 23.80% 24.00% 20.90% 23.92% 24.04% -
Total Cost 129,728 154,875 140,049 148,840 117,893 119,645 128,602 0.58%
-
Net Worth 621,564 612,147 614,350 635,424 642,484 584,565 581,725 4.50%
Dividend
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Div 16,951 - 3,530 - 42,361 - 3,421 189.79%
Div Payout % 107.86% - 22.94% - 261.60% - 23.23% -
Equity
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Net Worth 621,564 612,147 614,350 635,424 642,484 584,565 581,725 4.50%
NOSH 941,765 941,765 706,330 706,026 706,026 706,026 684,383 23.64%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 10.81% 9.87% 9.90% 10.58% 12.08% 10.56% 10.28% -
ROE 2.53% 2.77% 2.51% 2.77% 2.52% 2.42% 2.53% -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 15.44 18.25 22.01 23.58 18.99 19.22 20.94 -18.33%
EPS 1.67 1.80 2.18 2.49 2.29 2.03 2.15 -15.46%
DPS 1.80 0.00 0.50 0.00 6.00 0.00 0.50 134.34%
NAPS 0.66 0.65 0.87 0.90 0.91 0.84 0.85 -15.48%
Adjusted Per Share Value based on latest NOSH - 706,026
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 15.12 17.86 16.16 17.30 13.94 13.91 14.90 0.97%
EPS 1.63 1.76 1.60 1.83 1.68 1.47 1.53 4.29%
DPS 1.76 0.00 0.37 0.00 4.40 0.00 0.36 187.22%
NAPS 0.6462 0.6364 0.6387 0.6606 0.6679 0.6077 0.6047 4.51%
Price Multiplier on Financial Quarter End Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 -
Price 1.68 1.81 3.03 2.75 3.38 3.16 1.62 -
P/RPS 10.88 9.92 13.77 11.66 17.80 16.44 7.74 25.40%
P/EPS 100.67 100.49 139.03 110.23 147.37 155.66 75.27 21.32%
EY 0.99 1.00 0.72 0.91 0.68 0.64 1.33 -17.82%
DY 1.07 0.00 0.17 0.00 1.78 0.00 0.31 127.87%
P/NAPS 2.55 2.78 3.48 3.06 3.71 3.76 1.91 21.18%
Price Multiplier on Announcement Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 -
Price 1.60 1.62 2.49 2.93 3.42 4.04 3.15 -
P/RPS 10.36 8.88 11.31 12.43 18.01 21.02 15.04 -21.95%
P/EPS 95.88 89.94 114.25 117.44 149.11 199.01 146.36 -24.51%
EY 1.04 1.11 0.88 0.85 0.67 0.50 0.68 32.64%
DY 1.13 0.00 0.20 0.00 1.75 0.00 0.16 266.79%
P/NAPS 2.42 2.49 2.86 3.26 3.76 4.81 3.71 -24.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment